Search

everythinglearnresearchcommunity

for

Search:↓

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Finasteride, often used for hair loss, can potentially cause cataracts.

Centipedegrass extract may promote hair growth by activating certain cell pathways.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Two patients with the same genetic mutation had both blistering skin and easily pulled out hair.

Air pollution can damage hair and scalp, causing hair loss and inflammation.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

The document is a detailed medical reference on skin and genetic disorders.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

The model can effectively test gene functions and drug responses in human skin.

Dermoscopy helped correctly diagnose a skin condition that was previously misidentified as a different hair loss disease.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Blood pressure drugs can cause skin lupus, early treatment is key for baby herpes and diabetic foot ulcers, a certain vaccine works against genital herpes and HPV in women, more frequent light therapy helps psoriasis, smoking and drinking can worsen psoriasis, a cream clears up a type of skin cancer, and low iron levels don't cause chronic hair loss.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

A man's scalp infection, mistaken for bacterial, was actually a rare fungal infection treated successfully with antifungal medication.

Primary cicatricial alopecia causes permanent hair loss by destroying hair follicles, and its exact cause is unknown.

Baricitinib may effectively treat oral lichen planus.

A woman had a rare, non-cancerous skin growth on her face, which was removed and did not come back after a year.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.